RxDoctor Payments Data

Michael Falba, PA

Medical · New Orleans, LANPI 1275591323

Payments from drug & device makers

What this record shows

28 manufacturers reported payments, led by Intuitive Surgical at 47.8% of the total. Reporting peaked in 2024 at $2,815 and has fallen 88.5% since, to $323 in 2025.

$4,812in general payments, 2019–2025

Across 76 payments — averaging $63.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$2K
  • Gilead$364
  • CSL Behring$221
  • Inari Medical, Inc.$188
  • Axonics, Inc.$138
  • Procept Biorobotics Corporation$128
  • plus $1K from 22 others

What the payments were for

  • Travel & lodging$2,05843%
  • Food & beverage$2,75357%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,812 in reported general payments places this provider in the 85th percentile of 253 medical providers in Louisiana.

See all medical providers in Louisiana

Medicare billing

Part B allowed, 2024
$6,602
Medicare patients
30
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Testosterone Cypionate34$843
Tamsulosin Hcl101$694
Finasteride29$247
Venlafaxine Hcl ErVenlafaxine Hcl11$169
Oxybutynin Chloride ErOxybutynin Chloride19$43

Paid to pharmacies, not to this prescriber.

Other medical in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →